戻る Agenda
IVD Regulation and the Upcoming Changes in Regulatory Landscape
Session Chair(s)
Claudia Dollins, PhD, RAC
Vice President, Precision Medicines, Global Regulatory Affairs
GlaxoSmithKline, United States
IVD Regulation and the Upcoming Changes in Regulatory Landscape
Speaker(s)
Panel Discussion
Anna Hallersten, MSc
Roche Diagnostics, Switzerland
Head Regulatory Policy Europe
Panel Discussion
Sue Spencer
UL, United Kingdom
Head of Global Medical Devices
Panel Discussion
Stephen Lee
Medicines & Healthcare Products Regulatory Agency (MHRA), United Kingdom
Senior Regulatory Policy Manager